Mammalian Cell Processes
Industrial platforms, Underpinning bioscience, Novel technologies
28 - 30 January 2013
Mammalian cells have become the workhorse of the biotech industry due to their ability to produce of functional complex macromolecules at scale. The Mammalian Cell Processing MBI module is a three day course focusing on the specific challenges and opportunities associated with these cells. The course gives delegates a unique insight into platform technologies developed by world leaders in the field such as Lonza Biologics, MedImmune and Life Technologies. Talks from internationally renowned academics will discuss the underpinning bioscience and novel technologies currently in development to meet future demand.
There will also be the opportunity to interact with UCL’s extensive macromolecular research program (www.epsrc-cim-macromoleculartherapies.ac.uk) with particular focus on our new and unique single-use facility. Talks, tours and networking opportunities are supplemented with an interactive industryled case study which puts delegates in a real-life process development scenario.
Who should attend?
The course is particularly useful given the highly interdisciplinary nature of the field. Busy delegates from a wide variety of backgrounds will be given the opportunity to step back and understand the history behind the current state of the art: robust, efficient and defined production processes. Molecular biologists, process engineers, cell biologists, analytical scientists, project managers and chief scientific officers are just a few of the professionals that will benefit from the opportunity to shed light on many of the specialised approaches which have become embedded within the industry.
Programme
Monday 28 January
• Overview of mammalian cell culture
• Ultra scale down methodologies
• Cell line engineering
Tuesday 29 January
• Case Study: From development to production
• Modelling mammalian cell cultures
• The application of process analytical technologies
• Metabolic engineering and proteomics
• Scale-up of protein-free production processes
Wednesday 30 January
• Tour of UCL’s new Responsive Bioprocessing Facility
• Single use technologies for upstream processing
• Cell line selection
• Cell therapy
• Medium development and optimisation
Module Leader
Farlan Veraitch, UCL
Previous Expert Speakers
Suzanne Aldington, Lonza
Jon Dempsey, Life Technologies
Suzanne Gibson, MedImmune
Michelle Hutton, Lonza
Colin Jaques, Lonza Biologics
Sakis Mantalaris, Imperial College London
Carol Marshall, GlaxoSmithKline
Ronan O’Kennedy, Fujifilm Diosynth Biotechnologies
Mark Smales, University of Kent
The module costs £1300, with a £100 discount if you register and pay before 17 December.
Download the Flyer
Page last modified on 01 aug 12 14:18
